CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Communiqués Charles River Laboratories International, Inc.

Actions

CRL

US1598641074

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX Autres places de cotation 15:49:07 13/05/2026			Varia. 5j.	Varia. 1 janv.
165,28 ^USD	-2,02%		-8,35%	-16,51%

15:32	Charles River Laboratories et Medipost signent un protocole d'accord non exclusif pour faire progresser les solutions de tests GMP	RE
11/05	Charles River Laboratories International, Inc. accélère la pathologie numérique grâce à un flux de travail de bout en bout dopé à l'IA	CI

Communiqués

14:02	Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions	BU
11/05	Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow	BU
08/05	Charles River Laboratories International : Quarterly Report for Quarter Ending March 28, 2026 (Form 10-Q)	PU
07/05	Charles River Laboratories International : Q1 2026 Earnings Presentation	PU
07/05	Charles River: Q1 Earnings Snapshot	AQ
07/05	Charles River Laboratories Announces First-Quarter 2026 Results	BU
30/04	Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities	BU
21/04	Charles River Highlights Effectiveness of VCGs in Toxicology	BU
16/04	Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call	BU
09/04	Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association	BU
06/04	NYSE Content Update: Join Us and 6,500+ Attendees at Marquee AI Event HumanX	PR
02/03	Charles River Laboratories to Present at TD Cowen and Barclays Conferences	BU
25/02	Charles River Laboratories Provides Update on Planned Divestitures	BU
18/02	Charles River Laboratories International : Q4 2025 Earnings Presentation	PU
18/02	Charles River: Q4 Earnings Snapshot	AQ
18/02	Charles River Laboratories Announces Executive Appointments	BU
18/02	Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance	BU
21/01	Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call	BU
21/01	Charles River Enters Manufacturing Collaboration with Gazi University	BU
20/01	Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL	PR
13/01	Charles River Laboratories International : at the J.P. Morgan 44th Annual Healthcare Conference Presentation	PU
12/01	Charles River Laboratories Provides Business Updates	BU
08/01	Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan	BU
11/12	Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort	BU
01/12	HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS	PR